CARMEN GROUP INCORPORATED for BIOREFERENCE LABORATORIES, INC.
What was lobbied
3 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
Delaying implementation of the Clinical Laboratory Fees Schedule; Support Local Coverage Determination process legislation; Concern about FDA regulation of clinical labs; Authorization of the 4K score test for prostrate cancer; MAC review of lab testing
| Lobbyist | Covered position, as disclosed |
|---|---|
| WILLIAM ALAN SIGNER | — |
Government Issues GOV
Delaying implementation of the Clinical Laboratory Fees Schedule; Support Local Coverage Determination process legislation; Concern about FDA regulation of clinical labs; Authorization of the 4K score test for prostrate cancer; MAC review of lab testing; prior authorization of genetic testing
| Lobbyist | Covered position, as disclosed |
|---|---|
| WILLIAM ALAN SIGNER | — |
Medical/Disease Research/Clinical Labs MED
Delaying implementation of the Clinical Laboratory Fees Schedule; Support Local Coverage Determination process legislation; Concern about FDA regulation of clinical labs; Authorization of the 4K score test for prostrate cancer; MAC review of lab testing; National Coverage decision on genetic testing.
| Lobbyist | Covered position, as disclosed |
|---|---|
| WILLIAM ALAN SIGNER | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.